Patents by Inventor Suresh Kumar Mittal

Suresh Kumar Mittal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
    Publication number: 20250057935
    Abstract: Disclosed herein a unique cell line system to generate a novel bovine adenovirus vector that provides more gene insertion capabilities and better immunogenicity for inserted antigens. The unique cell line is used for generating and growing of the new adenovirus vectors for gene delivery or recombinant vaccine production.
    Type: Application
    Filed: June 20, 2024
    Publication date: February 20, 2025
    Inventor: Suresh Kumar Mittal
  • Adenoviral vector system for gene delivery
    Patent number: 12220454
    Abstract: Disclosed herein a unique cell line system to generate a novel bovine adenovirus vector that provides more gene insertion capabilities and better immunogenicity for inserted antigens. The unique cell line is used for generating and growing of the new adenovirus vectors for gene delivery or recombinant vaccine production.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: February 11, 2025
    Assignee: Purdue Research Foundation
    Inventor: Suresh Kumar Mittal
  • NOVEL VACCINE FORMULATIONS FOR MYCOBACTERIUM TUBERCULOSIS AND USE OF THEREOF
    Publication number: 20240366741
    Abstract: The present invention discloses a recombinant adenovirus vector of a replication-defective human adenovirus (HAdv85C5) or a bovine adenovirus (BAdv85C5) comprising a recombinant adenovirus vector having a heterologous DNA segment encoding mycobacterial Ag85B-p25 epitope (SEQ ID NO: 1), mycobacterial Ag85B-p25 epitope fusion of autophagy-inducing peptide-C5 (SEQ ID NO: 2), or a substantially homologous functional fragment thereof. The vector, having a heterologous DNA segment of SEQ ID NO: 3, SEQ ID NO: 4, or a substantially homologous functional fragment thereof, is an effective vaccine for therapeutically or prophylactically immunizing a subject for protection of infections by various microorganisms, especially Mycobacterium tuberculosis (Mtb), which causes the widespread tuberculosis. Methods of uses and pharmaceutical composition matters are within the scope of this disclosure.
    Type: Application
    Filed: March 8, 2022
    Publication date: November 7, 2024
    Applicants: Purdue Research Foundation, HOUSTON METHODIST RESEARCH INSTITUTE
    Inventors: Suresh Kumar Mittal, Chinnaswamy Jagannath
  • NOVEL ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
    Publication number: 20220288188
    Abstract: Disclosed herein a unique cell line system to generate a novel bovine adenovirus vector that provides more gene insertion capabilities and better immunogenicity for inserted antigens. The unique cell line is used for generating and growing of the new adenovirus vectors for gene delivery or recombinant vaccine production.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 15, 2022
    Applicant: Purdue Research Foundation
    Inventor: Suresh Kumar Mittal
  • Adenoviral vector system for gene delivery
    Patent number: 10968464
    Abstract: Disclosed herein a unique cell line system to generate a novel bovine adenovirus vector that provides more gene insertion capabilities and better immunogenicity for inserted antigens. The unique cell line is used for generating and growing of the new adenovirus vectors for gene delivery or recombinant vaccine production.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: April 6, 2021
    Assignee: Purdue Research Foundation
    Inventor: Suresh Kumar Mittal
  • NOVEL ADENOVIRAL VECTOR SYSTEM FOR GENE DELIVERY
    Publication number: 20190292562
    Abstract: Disclosed herein a unique cell line system to generate a novel bovine adenovirus vector that provides more gene insertion capabilities and better immunogenicity for inserted antigens. The unique cell line is used for generating and growing of the new adenovirus vectors for gene delivery or recombinant vaccine production.
    Type: Application
    Filed: March 20, 2019
    Publication date: September 26, 2019
    Applicant: Purdue Research Foundation
    Inventor: Suresh Kumar Mittal